Milebot Robotics

Shenzhen, Guangdong, ChinaFounded 2016101–250 employeesen.milebot.com.cn

Neurorehabilitation and assistive tech

Milebot Robotics is a medical rehabilitation robotics company developing intelligent systems and products to support gait rehabilitation. Its portfolio includes lower-limb rehabilitation exoskeletons, designed to help people with disabilities and older adults undertake rehabilitation training.

Visit en.milebot.com.cn ↗

Founded: 2016
Employees: 101–250

reccy insights

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

Recent highlights

Milebot Robotics’ most clearly documented milestones in 2026 were a financing and a leadership change. On Aug 26, 2026, the company announced a Series B of CNY 100 million, equivalent to approximately $14.88 million, with China Capital Management identified as the lead investor. The following day, Chen Kangning was appointed CEO. The appointment was described as bringing multinational healthcare experience relevant to regulatory work, hospital channels, pricing, and commercialization. Coverage of the financing also characterized the company as profitable, although the available figures do not include financial statements or a profitability measure. Milebot’s listed offerings span lower-limb rehabilitation exoskeletons, a walking-assistance robot, and a cloud rehabilitation platform. Its product descriptions target rehabilitation needs across adults, children, and stroke patients, with several training modes and gait support. The company also reports six granted patents. These milestones suggest a combination of capital support and an effort to strengthen healthcare commercialization capabilities, but public details about the financing’s use, hospital deployments, clinical outcomes, and revenue contribution remain limited.

Market position

Milebot Robotics operates at the intersection of medical devices, rehabilitation care, robotics, sensors, and connected health. Its portfolio is more specialized than a general-purpose robotics offering: it includes lower-limb exoskeletons for rehabilitation, a walking-assistance robot, and a cloud platform intended to support provider decision-making. The stated technical approach combines flexible-actuator interaction, motion control, posture detection, and rehabilitation data systems. The relevant competitive field includes developers of rehabilitation exoskeletons and gait-training systems, where differentiation typically depends on usability, therapy workflows, evidence, regulatory status, service support, and hospital access. Milebot’s 2026 Series B and CEO appointment indicate continued investment in financing and commercialization, but do not by themselves establish market share or product superiority. Its position is best described as a Shenzhen-based medical rehabilitation robotics specialist with a broad, condition-oriented product portfolio and limited public comparative-performance evidence.

Growth & opportunities

Founded in 2016, Milebot Robotics has a funding history spanning an Angel round in April 2017, a Seed round in May 2018, Series A in August 2020, a Venture Round in February 2022, and Series B in August 2026. The Aug 26, 2026 Series B is the clearest disclosed financing milestone: CNY 100 million, or approximately $14.88 million, led by China Capital Management. The company’s listed products extend beyond lower-limb exoskeletons to a walking-assistance robot and a cloud rehabilitation platform, indicating a product portfolio broader than a single device. Chen Kangning’s appointment as CEO on Aug 27, 2026 is another potential inflection point, with healthcare experience intended to support regulation, hospital channels, pricing, and commercialization. The company is categorized in the 101–250 employee range, but that range does not reveal hiring pace.

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

What makes Milebot Robotics distinct

reccy insights

What makes Milebot Robotics distinct

01Develops medical rehabilitation robots, including lower-limb exoskeletons designed to support gait training.
02Uses flexible-actuator-based robot interaction technology in rehabilitation products.
03Combines robotics with the Internet of Things, big data, and AI to build intelligent rehabilitation systems.
04Product portfolio addresses multiple rehabilitation needs, including children's motor training and walking assistance for stroke patients.
05The company describes its team as having robotics, rehabilitation, and control-algorithm expertise, with dozens of invention patents.

Technology & products6

Technology & products

H Series Lower Limb Exoskeleton Rehabilitation Robot
A wearable exoskeleton robot using flexible actuators to provide active rehabilitation training for lower-limb motor dysfunction.
A Series Lower Limb Exoskeleton Rehabilitation Robot
A lower-limb exoskeleton robot offering multiple functional modes for different stages of rehabilitation therapy.
RELAX Series Children's Lower Limb Exoskeleton Robot
A lower-limb exoskeleton robot designed to help children improve active motor function through multiple training modes.
MAX Series Walking Assistance Robot
A walking-assistance robot designed to support gait on the affected side for stroke patients and enhance rehabilitation training.
Three Thousand Steps Lower Limb Exoskeleton Robot
A lightweight lower-limb exoskeleton supporting multiple training modes and repetitive exercises to help users relearn walking.
Smart Rehabilitation Cloud Platform
A cloud-based platform using AI and big data to support rehabilitation services and healthcare-provider decision-making.

Show all 6 products

+ 3 more: MAX Series Walking Assistance Robot, Three Thousand Steps Lower Limb Exoskeleton Robot, Smart Rehabilitation Cloud Platform

Recent updates1

Launches, partnerships and team changes from press coverage

Aug 27, 2026Team change
Milebot Robotics appointed Chen Kangning as CEO. Her multinational healthcare background is expected to strengthen regulatory, hospital-channel, pricing, and commercialization capabilities.
jixin.tech

Similar companies

Show all 6 companies

About Milebot Robotics

Products: H Series Lower Limb Exoskeleton Rehabilitation Robot, A Series Lower Limb Exoskeleton Rehabilitation Robot, RELAX Series Children's Lower Limb Exoskeleton Robot, MAX Series Walking Assistance Robot, Three Thousand Steps Lower Limb Exoskeleton Robot, Smart Rehabilitation Cloud Platform
Leadership: Chen Gong, FounderChen Kangning, CEO
Focus areas: Rehabilitation robotics, medical robotics, exoskeletons, gait rehabilitation, medical devices, digital health, internet of things, artificial intelligence
Headquarters: Shenzhen, Guangdong, China
Founded: 2016
Employees: 101–250
Patents granted: 6 (Crunchbase)
Trademarks: 1